Artwork

内容由Leonard Lopate at Large on WBAI Radio in New York提供。所有播客内容(包括剧集、图形和播客描述)均由 Leonard Lopate at Large on WBAI Radio in New York 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

JIM GERAGHTY ON INSIDE THE ORPHAN DRUG REVOLUTION

53:38
 
分享
 

Manage episode 344471028 series 2413465
内容由Leonard Lopate at Large on WBAI Radio in New York提供。所有播客内容(包括剧集、图形和播客描述)均由 Leonard Lopate at Large on WBAI Radio in New York 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
(10-17-22) Jim Geraghty has been a passionate participant in the orphan drug revolution since its inception, a leader in the field as a strategy consultant, biotechnology executive, and venture entrepreneur. Advances in medicine have made possible better treatments for widespread, familiar human illnesses like cancer, diabetes, and heart disease. Yet there are thousands of much less common diseases, most of genetic origin, each classed as "rare" because it afflicts only a small number of people. According to Jim Geraghty these patient groups were long ignored by a pharmaceutical industry that judged them too small to provide a return on the investment needed to develop an effective remedy. Yet these "orphaned" diseases collectively caused misery and expense, often far greater than did more common ailments, for tens of millions of individuals and their families. In his book, Inside The Orphan Drug Revolution: The Promise of Patient-Centered Biotechnology, Jim Geraghty provides eyewitness accounts of advances as they occurred and portraits of the pioneering scientists and physicians, tireless activists, and visionary business leaders who made the revolution happen. Join us for a discussion when Jim Geraghty addresses questions such as: why do drugs to treat orphan diseases cost so much - how can we ensure they are affordable - how can their effectiveness be responsibly assessed - how can access to them be expanded internationally and more on this installment of Leonard Lopate at Large.
  continue reading

866集单集

Artwork
icon分享
 
Manage episode 344471028 series 2413465
内容由Leonard Lopate at Large on WBAI Radio in New York提供。所有播客内容(包括剧集、图形和播客描述)均由 Leonard Lopate at Large on WBAI Radio in New York 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
(10-17-22) Jim Geraghty has been a passionate participant in the orphan drug revolution since its inception, a leader in the field as a strategy consultant, biotechnology executive, and venture entrepreneur. Advances in medicine have made possible better treatments for widespread, familiar human illnesses like cancer, diabetes, and heart disease. Yet there are thousands of much less common diseases, most of genetic origin, each classed as "rare" because it afflicts only a small number of people. According to Jim Geraghty these patient groups were long ignored by a pharmaceutical industry that judged them too small to provide a return on the investment needed to develop an effective remedy. Yet these "orphaned" diseases collectively caused misery and expense, often far greater than did more common ailments, for tens of millions of individuals and their families. In his book, Inside The Orphan Drug Revolution: The Promise of Patient-Centered Biotechnology, Jim Geraghty provides eyewitness accounts of advances as they occurred and portraits of the pioneering scientists and physicians, tireless activists, and visionary business leaders who made the revolution happen. Join us for a discussion when Jim Geraghty addresses questions such as: why do drugs to treat orphan diseases cost so much - how can we ensure they are affordable - how can their effectiveness be responsibly assessed - how can access to them be expanded internationally and more on this installment of Leonard Lopate at Large.
  continue reading

866集单集

Tất cả các tập

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南